Decreased homovanillic acid and 5‐hydroxyindoleacetic acid levels in the cerebrospinal fluid of patients with Dravet syndrome with parkinsonism

Documenti analoghi

• Practical considerations for the use of fenfluramine to manage patients with Dravet syndrome or Lennox–Gastaut syndrome in clinical practice
  di: Elaine C. Wirrell, et al.
  Pubblicazione: (2024)
• Stiripentol use in Dravet syndrome patients in the USA : Results of a real‐world study
  di: Elaine Wirrell, et al.
  Pubblicazione: (2025)
• Communicating a diagnosis of Dravet syndrome to parents/caregivers: An international Delphi consensus
  di: Andreas Brunklaus, et al.
  Pubblicazione: (2025)
• Nonseizure symptoms and broader seizure impacts in patients with Dravet syndrome and Lennox–Gastaut syndrome in clinical practice settings: Results from a multinational survey
  di: Drishti Shah, et al.
  Pubblicazione: (2025)
• Antiseizure medication prescribing in people with Dravet syndrome: An analysis of real‐time administrative data
  di: Kevin Y. Xu, et al.
  Pubblicazione: (2024)